Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control study

The 21-gene recurrence score (RS) is increasingly being used for patients with early stage, hormone receptor-positive, Her-2-negative breast cancer. However, these results are largely from populations with infiltrating ductal carcinoma (IDC). The clinical value of RS testing in mucinous carcinoma ha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer
Autors principals: Wang, Wei, Chen, Xiaosong, Lin, Lin, Fei, Xiaochun, Garfield, David H., Hong, Jin, Gao, Weiqi, Zhu, Siji, Wu, Jiayi, Huang, Ou, He, Jianrong, Li, Yafen, Zhu, Li, Chen, Weiguo, Shen, Kunwei
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160674/
https://ncbi.nlm.nih.gov/pubmed/30271480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27291
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars